Status:

COMPLETED

Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section

Lead Sponsor:

HealthPartners Institute

Collaborating Sponsors:

Regions Hospital

Conditions:

Obstetric Labor Complications

Cesarean Section

Eligibility:

All Genders

Brief Summary

This study is an evaluation of a Quality Improvement (QI) project addressing delivery of the impacted fetal head being conducted at Regions Hospital. This study aims to determine the morbidity of seco...

Detailed Description

Cesarean deliveries performed during the second stage of labor can be difficult due to impaction of the fetal head deep in the maternal pelvis and is associated with increased risk of both maternal an...

Eligibility Criteria

Inclusion

  • Patient: The patient study population includes all patients age 18-45 who underwent cesarean section during the second stage of labor (during the time period July 2016-June 2019 at Regions Hospital and Methodist Hospital) and their infants. Second stage is defined as the time between complete cervical dilation and delivery of the infant.
  • Medical staff: All staff members (staff physicians, residents, nurses, surgical technicians) at Regions Hospital who practice in the Birth Center who underwent required simulation education regarding delivery of impacted fetal heads during second stage cesarean section and completed the surveys as part of the QI project. Note: Medical staff were not enrolled in the research study; rather, staff survey data from the QI project was a data source for the study.

Exclusion

  • Patient: Exclusion criteria include patients who underwent cesarean section in second stage for malpresentations (i.e., breech and noncephalic presentations) and patients who underwent cesarean section prior to 37 weeks gestation.
  • Medical staff: No exclusion criteria

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2019

Estimated Enrollment :

409 Patients enrolled

Trial Details

Trial ID

NCT03387189

Start Date

January 1 2018

End Date

June 30 2019

Last Update

November 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Regions Hospital

Saint Paul, Minnesota, United States, 55101